| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $100,344 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Wendell Amy McBride | director | 1 | $100,344 | 0 | $0 | $100,344 |
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, …
Over the last 12 months, insiders at Solventum Corporation have bought $100,344 and sold $0 worth of Solventum Corporation stock.
On average, over the past 5 years, insiders at Solventum Corporation have bought $100,344 and sold $646.36M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Wendell Amy McBride (director) — $100,344.
The last purchase of 1,475 shares for transaction amount of $100,344 was made by Wendell Amy McBride (director) on 2026‑03‑10.
| 2026-03-10 | Wendell Amy McBride | director | 1,475 0.0008% | $68.03 | $100,344 | +16.27% | ||
| 2025-08-15 | Sale | 3M CO | 10 percent owner | 8.8M 4.3262% | $73.45 | $646.36M | +4.76% |
| Increased Positions | 404 | +39.92% | 10M | +8.2% |
| Decreased Positions | 391 | -38.64% | 9M | -7.06% |
| New Positions | 141 | New | 908,510 | New |
| Sold Out Positions | 71 | Sold Out | 2M | Sold Out |
| Total Postitions | 1,025 | +1.28% | 126M | +1.14% |